GLP-1 Agonists Associated with Doubled Risk of Neovascular AMD, Study Finds
Blockbuster meds, blockbuster risks? Trending GLP-1s (like Ozempic) are now raising red flags for nAMD. A new population-based cohort study…
Inspiring Award Lectures at ARVO 2025 Highlight Decades of Visionary Work
Day 2 of the annual meeting of The Association for Research in Vision and Ophthalmology (ARVO 2025) in Salt Lake…
popular posts